All > Alabama > Milwaukee

metreleptin for Partial Lipodystrophy

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Partial Lipodystrophymetreleptin - Drug
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a daily injection of metreleptin is safe and effective for people with Partial Lipodystrophy.

Eligible Conditions
  • Partial Lipodystrophy

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Similar Trials

1
ARO-ANG 3 Injection
1
ARD-101
1
REGN4461

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: 12 months

12 months
Change from Baseline to each assessment time point in quality of life (QoL) in all subjects
Change from baseline to months 9 and 12 in HbA1c in subjects with partial lipodystrophy (PL)
Percent change from baseline to months 9 and 12 in fasting TGs in subjects with partial lipodystrophy (PL)
Safety analysis of AEs, AESIs, SAEs by treatment arm
6 months
Change from baseline to month 6 in HbA1c in subjects with partial lipodystrophy (PL)
Percent change from Baseline to month 6 in fasting TGs in subjects with partial lipodystrophy (PL)

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

2
ARO-ANG 3 Injection
2
ARD-101
2
REGN4461

Trial Design

2 Treatment Groups

metreleptin
1 of 2
placebo
1 of 2

Active Control

Non-Treatment Group

65 Total Participants · 2 Treatment Groups

Primary Treatment: metreleptin · Has Placebo Group · Phase 3

placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug
metreleptin
Drug
ActiveComparator Group · 1 Intervention: metreleptin · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Amryt PharmaLead Sponsor
4 Previous Clinical Trials
352 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top